<html>
<head>
<title>'Pan-variant' COVID vaccine could defang future strains thanks to machine learning | TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">由于机器学习，泛变异 COVID 疫苗可以方得未来的菌株</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2023/03/09/pan-variant-covid-vaccine-could-defang-future-strains-thanks-to-machine-learning/amp/">https://web.archive.org/web/https://techcrunch.com/2023/03/09/pan-variant-covid-vaccine-could-defang-future-strains-thanks-to-machine-learning/amp/</a></blockquote><div><div class="content">

			
	
		
		

		
<p class="amp-featured-image translated"><amp-img src="https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?w=1024" class="attachment-post-thumbnail size-post-thumbnail wp-post-image amp-wp-enforced-sizes i-amphtml-layout-intrinsic i-amphtml-layout-size-defined" alt="A conceptual illustration showing a DNA aptamer strand and virus cell" srcset="https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg 4000w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=150,113 150w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=300,225 300w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=768,576 768w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=680,510 680w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=1536,1152 1536w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=2048,1536 2048w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=1200,900 1200w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=50,38 50w" layout="intrinsic" i-amphtml-layout="intrinsic"> <i-amphtml-sizer class="i-amphtml-sizer"> <img alt="" aria-hidden="true" class="i-amphtml-intrinsic-sizer" role="presentation" src=""/> </i-amphtml-sizer> <noscript> <img src="../Images/18eb67472305777bb88a77aa138cb6c2.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="A conceptual illustration showing a DNA aptamer strand and virus cell" decoding="async" loading="lazy" srcset="https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg 4000w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=150,113 150w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=300,225 300w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=768,576 768w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=680,510 680w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=1536,1152 1536w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=2048,1536 2048w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=1200,900 1200w, https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?resize=50,38 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20230403134635im_/https://techcrunch.com/wp-content/uploads/2021/03/achiko-aptamer_and_covid.jpg?w=1024"/> </noscript> </amp-img></p><p class="translated"><strong>图片来源:</strong> <a href="https://web.archive.org/web/20230403134635/https://www.achiko.com/" target="_blank">阿奇子</a></p><p class="translated">据麻省理工学院的研究人员称，一种具有机器学习扭曲的疫苗新方法可以结束加强剂和季节性变异疫苗。这种“泛变异”疫苗将忽略病毒本身，但通过打击受感染的细胞来快速控制感染。</p>
<p class="translated">非常明确的是，这仍在动物试验中，离部署还很远。但随着 COVID 成为人类群体中的常驻病毒，需要比偶尔加强剂更持久的解决方案来应对特别糟糕的菌株。</p>
<p class="translated">问题是，尽管 mRNA 疫苗令人惊叹，但它们是反应性的，而不是主动的:你看到一个变体，你对它的刺突蛋白或其他一些独特特征进行采样，然后你将它植入免疫系统，这样它就知道要警惕了。这有点像让一只搜救犬嗅一个迷路的徒步旅行者的物品。</p>
<p class="translated">麻省理工学院计算机科学和人工智能实验室的研究人员希望找到另一种更持久的方法来保护身体免受 COVID 攻击。描述他们发现的论文发表在今天的《T4 免疫学前沿》杂志上。</p>
<p class="translated">该小组决定放弃攻击病毒本身的想法，因为它最显著的特征，刺突蛋白，总是在变化。相反，他们专注于某些可靠地出现在被病毒感染的细胞表面的分子信号。如果这些能够被早期发现，免疫系统的 T 细胞能够快速部署，感染将在达到危险甚至潜在的感染水平之前被阻止。</p>
<p class="translated">这些表面信号被称为人类白细胞抗原，它们向 T 细胞呈递各种肽，有点像升起信号旗。如果一切正常，这是常见的肽组合，T 细胞继续前进。如果出了问题，病毒的一个片段可能会被吊到旗杆上，T 细胞就会开火。</p>
<p class="translated">那么机器学习和这一切有什么关系呢？有很多数据记录了 COVID 中发现的各种蛋白质和氨基酸链，以及它们一旦渗入细胞后会变成什么样，以及细胞如何使用 HLA 指示它们被感染。</p>
<p class="translated">机器学习算法擅长解决类似这样的优化问题，在这种情况下，必须对大量有噪声的数据进行排序，以获得特定的质量组合。在这种情况下，他们设计了算法来对相关肽进行分类，并选择了大约 30 种在所有病毒版本中存在或“保守”的肽，但这些肽也与 HLA 相关，并有可能被用作 T 细胞看到的标志。</p>
<p class="translated">给予我们的 HLA 版本和这种新疫苗的转基因小鼠在感染后的短期内表现出更大的免疫应答，没有一只死于该病毒。</p>
<p class="translated">该论文的主要作者之一、麻省理工学院博士生布兰登·卡特在一篇麻省理工学院的新闻文章中说:“这项研究在一个活生生的系统——一只真正的老鼠身上提供了证据，证明我们用机器学习设计的疫苗能够抵御 COVID 病毒。”。</p>
<p class="translated">一个有趣的可能好处是，免疫功能低下的人可能从这种方法中获得重要的保护，而 mRNA 疫苗对他们不起作用。“Long COVID”患者也可以通过对其特别有抵抗力的感染进行更全面的免疫攻击来获得一些缓解。</p>
<p class="translated">正如研究摘要所说:</p>
<blockquote><p class="translated">在 MIT-T-COVID 免疫的小鼠中检测不到特异性抗体应答，这表明单独的特异性 T 细胞应答可以有效地减弱新型冠状病毒感染的发病机制。我们的结果表明，值得对泛变异 T 细胞疫苗进行进一步研究，包括对无法产生中和抗体或无法帮助缓解 Long COVID 的个体。</p></blockquote>
<p class="translated">这是一个有希望的探索方向，也是利用计算进步为全球健康服务的一个好方法。但同样重要的是，要认识到“泛变异”方案还为时过早。一方面，它可能与现有疫苗一起发挥作用，也可能与现有疫苗对抗——如果免疫应答疫苗的最佳肽是那些通过 mRNA 启动而被破坏的肽，该怎么办？这两者会产生矛盾。太强的免疫反应也有附带损害的风险，错误地剔除模糊的信号细胞等等。</p>
<p class="translated">但这些都是很好的问题——之所以相关，是因为新疫苗的基本功能似乎奏效了。随着团队对这种有希望的方法进行更多的测试，我们会了解更多。</p>


		

			
	
		

			<amp-pixel src="https://web.archive.org/web/20230403134635im_/https://ampmetrics.techcrunch.com/pixel.gif" placeholder="" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>
		<amp-analytics data-credentials="include" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed">
		
	</amp-analytics>
	<amp-pixel src="https://web.archive.org/web/20230403134635im_/https://pixel.wp.com/g.gif?v=ext&amp;blog=136296444&amp;post=2495523&amp;tz=-7&amp;srv=techcrunch.com&amp;host=techcrunch.com&amp;rand=RANDOM&amp;ref=DOCUMENT_REFERRER" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_googleanalytics" type="googleanalytics" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_comscore" type="comscore" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/><amp-analytics id="tc_parsely" type="parsely" class="i-amphtml-layout-fixed i-amphtml-layout-size-defined" i-amphtml-layout="fixed"/>	</div>

</div>    
</body>
</html>